Painless wearable microneedle device may reduce trips to doctors’ offices
ALBUQUERQUE, N.M. — Patients trying to navigate today’s complex medical system with its costly laboratory analyses might prefer a pain-free home diagnostic device, worn on the wrist, that can analyze, continuously record and immediately remedy low electrolyte levels.
Runners, athletes in other strenuous sports and soldiers on long missions also might prefer immediate knowledge of their electrolytic states as an aid to improved performance. Electrolytes such as potassium, calcium, magnesium and other salts are key in carrying nerve impulses that tell the heart and other muscles when to contract or relax.
In response to this need, Sandia National Laboratories researcher Ronen Polsky and colleagues are patenting a prototype model that can analyze various electrolyte levels on the spot, yet fit in a palm or be worn on a wrist. The device, when commercially available, could decrease the time ordinary citizens, athletes and the military must spend in emergency rooms, lab testing facilities or doctors’ offices.
“This is the future of personalized health care,” said Polsky. “These wearable technologies are just starting to come out in different forms. It’s inevitable that people will go there.”
The device is painless because it employs microneedles so tiny they don’t traumatize nerves when pressed into the skin. It also samples only interstitial fluid — the liquid between skin cells. Thus the device has the potential for long-term, noninvasive use.
“We’re proposing a minimally invasive way to move away from centralized laboratory testing,” said Polsky.
In a paper published as a cover feature in the June issue of Advanced Healthcare Materials, Polsky, Sandia colleagues and University of North Carolina and North Carolina State University graduate student Phil Miller describe using a laser to create strong hollow microneedles that suck nearly infinitesimal amounts of colorless fluid from just beneath the skin’s surface. The paper demonstrates that tiny amounts of potassium passed unhindered through the microneedle pores into a fluidic cartridge containing carbon electrodes. These measured the amount of this key electrolyte without being confused by the presence of other electrolytes in the fluid.
Miller said it’s easy to change the selectivity of the carbon electrodes to detect and measure other such electrolytes like sodium or calcium in the same device. “We want to make the device wearable, noninvasive, and with real-time readout to constantly measure things a doctor might normally order for laboratory tests,” he said.
Eventually the researchers envision a “sense-respond” device where some needles can read electrolytes while other needles, on demand, send electrolytes to make up for deficiencies.
Said Polsky, “Investors have expressed interest in commercial applications for the technology in healthcare and sports medicine, among other areas.”
University of New Mexico (UNM) physician and researcher Justin Baca, who will lead human testing of the device, added, “Development of this benchtop device into a handheld model for consumers and patients will be a true partnership between a clinician and an engineer.”
Sometimes sensor technologies work well, but problems arise when they are adapted to living systems, Baca said. “We’re trying to get at this problem from the beginning to develop the best needle geometry.”
Baca, with a background in physical chemistry and a practice in emergency medicine, said he has initial approval from UNM’s Human Research Protection Office review board to start tests. He’s interested, he said, because “it’s hard, using traditional methods, to take blood samples continuously.” Interstitial fluids should be far easier to sample, Baca said.
The initial sensor work was funded by Sandia’s Laboratory Directed Research and Development program and the U.S. Defense Threat Reduction Agency. Others working on the project include University of North Carolina and North Carolina State professor Roger Narayan.
Sandia National Laboratories is a multi-program laboratory operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corp., for the U.S. Department of Energy’s National Nuclear Security Administration. With main facilities in Albuquerque, N.M., and Livermore, Calif., Sandia has major R&D responsibilities in national security, energy and environmental technologies and economic competitiveness.
Sandia news media contact: Neal Singer, email@example.com, (505) 845-7078